Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market episode artwork

EPISODE · Mar 12, 2026 · 8 MIN

Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market

from Unbreakable Vitality · host Daniel Rasmussen

Most weight loss interventions treat the symptom. Retatrutide addresses the system.In this episode of Unbreakable Vitality, we break down why Retatrutide, a first-in-class triple hormone receptor agonist, is becoming a cornerstone of precision metabolic medicine for high-performers with stubborn visceral fat, insulin resistance, and inflammatory markers that won't budge despite optimized lifestyle.This episode covers: why Retatrutide outperforms Semaglutide and Tirzepatide, how we prepare the metabolic terrain before prescribing it, and the full biomarker panel we use to protect lean mass, thyroid function, and hormonal balance throughout the protocol.This isn't a shortcut. It's a precision reset, designed for people ready to reclaim their metabolic baseline and build on it.🎟 Join the next Ageless Future Longevity Summit (Seattle)https://agelessfutureseattle.com/event/Join Our CommunityConnect with us to get the latest insights on longevity, precision medicine, and health optimization strategies to help you thrive. Follow us on social media for exclusive tips, updates, and cutting-edge therapies to extend your HealthSpan:🌟 Instagram: Follow @pinnaclehealth | @ageless.future.seattle for daily health tips and behind-the-scenes content.📘 Facebook: Like Pinnacle Integrative Health for updates on our latest episodes and events.🎥 YouTube: Subscribe to @IntegrativeMedicineSeattle for in-depth videos on Unbreakable Vitality and more.Get Started TodayTake our quick quiz at www.echelon-longevity.com/quiz to discover your personalized path to longevity. Don’t miss out, connect with us today and take control of your health journey!🌐 https://agelessfutureseattle.com/event/📩 Contact us to begin your journey!

Episode metadata supplied by the publisher feed · Published Mar 12, 2026

Embed this episode

Most weight loss interventions treat the symptom. Retatrutide addresses the system. In this episode of Unbreakable Vitality, we break down why Retatrutide, a first-in-class triple hormone receptor agonist, is becoming a cornerstone of precision metabolic medicine for high-performers with stubborn visceral fat, insulin resistance, and inflammatory markers that won't budge despite optimized lifestyle. This episode covers: why Retatrutide outperforms Semaglutide and Tirzepatide, how we prepare t...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Retatrutide: The Triple Agonist That Outperforms Every GLP-1 on the Market

0:00 8:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Unbreakable Vitality?

This episode is 8 minutes long.

When was this Unbreakable Vitality episode published?

This episode was published on March 12, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Unbreakable Vitality episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!